Module: Reverse Impact
Step 1: Select Cancer and Mutation type
  
ACC: Adrenocortical Carcinoma
BLCA: Bladder Urothelial Carcinoma
BRCA: Breast Invasive Carcinoma
CESC: Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma
CHOL: Cholangiocarcinoma
COAD: Colon Adenocarcinoma
DLBC: Lymphoid Neoplasm Diffuse Large B-cell Lymphoma
ESCA: Esophageal Carcinoma
GBM: Glioblastoma Multiforme
HNSC: Head and Neck Squamous Cell Carcinoma
KICH: Kidney Chromophobe
KIRC: Kidney Renal Clear Cell Carcinoma
KIRP: Kidney Renal Papillary Cell Carcinoma
LAML: Acute Myeloid Leukemia
LGG: Brain Lower Grade Glioma
LIHC: Liver Hepatocellular Carcinoma
LUAD: Lung Adenocarcinoma
LUSC: Lung Squamous Cell Carcinoma
MESO: Mesothelioma
OV: Ovarian Serous Cystadenocarcinoma
PAAD: Pancreatic Adenocarcinoma
PCPG: Pheochromocytoma and Paraganglioma
PRAD: Prostate Adenocarcinoma
READ: Rectum Adenocarcinoma
SARC: Sarcoma
SKCM: Skin Cutaneous Melanoma
STAD: Stomach Adenocarcinoma
TGCT: Testicular Germ Cell Tumors
THCA: Thyroid Carcinoma
THYM: Thymoma
UCEC: Uterine Corpus Endometrial Carcinoma
UCS: Uterine Carcinosarcoma
UVM: Uveal Melanoma


ACC BLCA BRCA CESC CHOL
COAD DLBC ESCA GBM HNSC
KICH KIRC KIRP LAML LGG
LIHC LUAD LUSC MESO OV
PAAD PCPG PRAD READ SARC
SKCM STAD TGCT THCA THYM
UCEC UCS UVM

Step 2: Input Genes
OR
Select ...
OR



Step 3: Advanced Options





 Cross-Cancer Comparison
    (runtime: ~30sec for 2 cancers )

 Hierarchical clustering and heatmap
    ( Number of input genes > 1;
     runtime: ~30sec per cancer
)